Related references
Note: Only part of the references are listed.Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study
Elizabeth V. Arkema et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Sex Differences in Response to Anti-Tumor Necrosis Factor Therapy in Early and Established Rheumatoid Arthritis - Results from the DANBIO Registry
Damini Jawaheer et al.
JOURNAL OF RHEUMATOLOGY (2012)
Effectiveness of Rituximab in Patients with Rheumatoid Arthritis: Observational Study from the British Society for Rheumatology Biologics Register
Moetaza M. Soliman et al.
JOURNAL OF RHEUMATOLOGY (2012)
Sex Differences in Pain Scores and Localization in Inflammatory Arthritis: A Systematic Review and Metaanalysis
Cheryl Barnabe et al.
JOURNAL OF RHEUMATOLOGY (2012)
Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS
Keeranur Jayakumar et al.
RHEUMATOLOGY (2012)
Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of north america cohort of rheumatoid arthritis patients
Damini Jawaheer et al.
ARTHRITIS CARE & RESEARCH (2012)
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
P. P. Tak et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries
Xavier Mariette et al.
RHEUMATOLOGY (2011)
Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage
M. Ahlmen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
P. Emery et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Sex: a major predictor of remission in early rheumatoid arthritis?
K. Forslind et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register
K. L. Hyrich et al.
RHEUMATOLOGY (2006)
Influence of male sex on disease phenotype in familial rheumatoid arthritis
Damini Jawaheer et al.
ARTHRITIS AND RHEUMATISM (2006)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
P Emery et al.
ARTHRITIS AND RHEUMATISM (2006)
Sex steroid receptors in rheumatoid arthritis
M Ishizuka et al.
CLINICAL SCIENCE (2004)
Comparison between women and men with recent onset rheumatoid arthritis of disease activity and functional ability over two years (the TIRA project)
E Hallert et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Share Paper
